SELP and acute kidney injury: In this study, we first identified that P‐selectin expressed on injured ECs was a superior target for theranostics of ischemic AKI and designed P‐selectin‐targeted PBP‐EVs with binding selectivity to injured ECs for monitoring and treating IRI‐induced AKI.